cve.bz

CVE-2026-101451 oracle corporation siebel life sciences: Improper Access Control

8.7 highEPSS 0.2%

High (8.7) in oracle corporation siebel life sciences. EPSS 0.2% estimated probability of exploitation activity in the next 30 days.

On this page
Vulnerability in the Siebel Life Sciences product of Oracle Siebel CRM (component: Web UI). Supported versions that are affected are 17.0-26.9. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Siebel Life Sciences. Successful attacks require human interaction from a person other than the attacker and while the vulnerability is in Siebel Life Sciences, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all Siebel Life Sciences accessible data as well as unauthorized access to critical data or complete access to all Siebel Life Sciences accessible data. CVSS 3.1 Base Score 8.7 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:H/I:H/A:N).

Severity

CVSS 3.1

8.7 high
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:H/I:H/A:N
EPSS
0.2% (unchanged from 0.2% a week ago) estimated probability of exploitation activity in the next 30 days; 6th percentile. Scored 2026-11-17. A forecast for this CVE across the internet, not for your own systems.
CISA's assessment (SSVC)
Exploitation: none · Automatable: no · Technical impact: total, assessed 2026-11-03. From CISA's Vulnrichment in the CVE List: whether it is exploited, whether exploiting it can be automated, and how much control it gives.
CWEs
CWE-284 Improper Access Control
CWE-352 Cross-Site Request Forgery (Cross Site Reference Forgery)
OWASP Top 10
A01:2025 Broken Access Control
Published
Modified
NVD analysis
Awaiting analysis
Record from
the NVD, synced

Ask an AI about this CVE

Show the promptExplain CVE-2026-101451 for an engineer deciding whether to act. Use https://cve.bz/api/public/cves/CVE-2026-101451?via=ask-ai-copy and https://cve.bz/cve/CVE-2026-101451?via=ask-ai-copy as the source of truth: what is affected and which versions fix it, whether it is in CISA KEV, public exploits, and its EPSS (an internet-wide 30-day estimate of exploitation activity, not a forecast for my systems). If they give no fixed versions, use the CVE record https://cveawg.mitre.org/api/cve/CVE-2026-101451 or the vendor advisory, not third-party mirrors. Tell me how to check whether I am affected and how to verify a fix. Cite the sources and say where they are uncertain.

Opens a third-party assistant; its answer is its own, not cve.bz's. The prompt holds only this CVE's id and public links.

Affected

  • oracle corporation:siebel life sciences

Versions

From the CNA's record in the CVE List.

ProductAffected
Oracle Corporation Siebel Life Sciencesfrom 17.0 through 26.9

Attack patterns (CAPEC)

  • CAPEC-62 Cross Site Request Forgery Likelihood: High · Severity: Very High
  • CAPEC-111 JSON Hijacking (aka JavaScript Hijacking) Likelihood: High · Severity: High
  • CAPEC-462 Cross-Domain Search Timing Severity: Medium
  • CAPEC-467 Cross Site Identification Severity: Low

The attack patterns MITRE's CAPEC relates to this record's weaknesses, as MITRE names them. Credits. More on the page of CWE-284 (17).

References

Check your stackJSON